Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy

被引：0
|
作者：
Jingkai Liu
Qiaofei Liu
Xiang Zhang
Ming Cui
Tong Li
Yalu Zhang
Quan Liao
机构：
[1] Chinese Academy of Medical Sciences,Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College
来源：
Cancer Cell International | / 21卷
关键词：
Pancreatic cancer; Heterogeneity; Immune cell; Immune checkpoints; Immunotherapy; Transglutaminase 2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
    Liu, Jingkai
    Liu, Qiaofei
    Zhang, Xiang
    Cui, Ming
    Li, Tong
    Zhang, Yalu
    Liao, Quan
    [J]. CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [2] Clinical Impact of Molecular Subtyping of Pancreatic Cancer
    Xu, Zhou
    Hu, Kai
    Bailey, Peter
    Springfeld, Christoph
    Roth, Susanne
    Kurilov, Roma
    Brors, Benedikt
    Gress, Thomas
    Buchholz, Malte
    An, Jingyu
    Wei, Kongyuan
    Peccerella, Teresa
    Buechler, Markus W.
    Hackert, Thilo
    Neoptolemos, John P.
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [3] Two immune faces of pancreatic adenocarcinoma: Possible implication for immunotherapy
    Karakhanova, S.
    Werner, J.
    Bazhin, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 29 - 30
  • [4] Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
    Bazhin, Alexandr V.
    Shevchenko, Ivan
    Umansky, Viktor
    Werner, Jens
    Karakhanova, Svetlana
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (01) : 59 - 65
  • [5] Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
    Bazhin, Alexandr V.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S60 - S60
  • [6] Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
    Alexandr V. Bazhin
    Ivan Shevchenko
    Viktor Umansky
    Jens Werner
    Svetlana Karakhanova
    [J]. Cancer Immunology, Immunotherapy, 2014, 63 : 59 - 65
  • [7] Clinical immunotherapy in pancreatic cancer
    Ye, Xiaorong
    Yu, Yue
    Zheng, Xiaohu
    Ma, Hongdi
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (04)
  • [8] Clinical immunotherapy in pancreatic cancer
    Xiaorong Ye
    Yue Yu
    Xiaohu Zheng
    Hongdi Ma
    [J]. Cancer Immunology, Immunotherapy, 73
  • [9] Immune functions as a ligand or a receptor, cancer prognosis potential, clinical implication of VISTA in cancer immunotherapy
    Im, Eunji
    Sim, Deok Yong
    Lee, Hyo-Jung
    Park, Ji Eon
    Park, Woon Yi
    Ko, SeongGyu
    Kim, Bonglee
    Shim, Bum Sang
    Kim, Sung-Hoon
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 86 : 1066 - 1075
  • [10] Subtyping Pancreatic Cancer
    Biankin, Andrew V.
    Maitra, Anirban
    [J]. CANCER CELL, 2015, 28 (04) : 411 - 413
12345